PharmaBoardroom

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the US urges Congress to avoid restricting…

Kyoung-June Lee, CEO of JW CreaGene, lifts the lid on their novel technology of developing an immuno-oncology treatment from dendritic cells, which…

Dr BG Rhee, CEO of SCM Lifescience discusses their patented proprietary subfraction technology to extract high purity cell cultures, and the impact…

Mehdi Ferdjioui, GM for North West Africa at GE Healthcare explains the importance of his region to the global group and how GE’s innovative medtech…

Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city hospitals project, highlighting the…

Against an alluring backdrop, big-name pharma brands are now starting to spend heavily on in-country manufacturing, development and shared service…

Maria Begona Barragan Garcia, president of GEPAC – the Spanish Group of Patients with Cancer – discusses the necessity of the group and its role…

Enrique Ordieres, president of Cinfa Group, the leading Spanish generics company, highlights the importance of diversification and…

Moncef Meklati, Merck’s general manager for North West Africa, discusses the company's ambitions in the region, the key to successful joint ventures…

Over the last ten years, generic medicines have increased access to medicines by over 100% in 7 key therapeutic areas and have provided massive…

Last week, Bristol-Myers Squibb (BMS) announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will…

Juan Luis Fernández Balaguer, general manager of Laboratorios Combix, the Spanish affiliate of Zydus Cadila, shares the milestones achieved by the…